{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "19393961",
  "DateCompleted": {
    "Year": "2009",
    "Month": "05",
    "Day": "27"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "03",
    "Day": "31"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/S1473-3099(09)70083-0"
    ],
    "Journal": {
      "ISSN": "1474-4457",
      "JournalIssue": {
        "Volume": "9",
        "Issue": "5",
        "PubDate": {
          "Year": "2009",
          "Month": "May"
        }
      },
      "Title": "The Lancet. Infectious diseases",
      "ISOAbbreviation": "Lancet Infect Dis"
    },
    "ArticleTitle": "Stenotrophomonas maltophilia: an emerging opportunist human pathogen.",
    "Pagination": {
      "StartPage": "312",
      "EndPage": "323",
      "MedlinePgn": "312-23"
    },
    "Abstract": {
      "AbstractText": [
        "Stenotrophomonas maltophilia has emerged as an important opportunistic pathogen in the debilitated host. S maltophilia is not an inherently virulent pathogen, but its ability to colonise respiratory-tract epithelial cells and surfaces of medical devices makes it a ready coloniser of hospitalised patients. S maltophilia can cause blood-stream infections and pneumonia with considerable morbidity in immunosuppressed patients. Management of infection is hampered by high-level intrinsic resistance to many antibiotic classes and the increasing occurrence of acquired resistance to the first-line drug co-trimoxazole. Prevention of acquisition and infection depends upon the application of modern infection-control practices, with emphasis on the control of antibiotic use and environmental reservoirs."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute for Infectious Diseases, University of Bern, Bern, Switzerland."
          }
        ],
        "LastName": "Looney",
        "ForeName": "W John",
        "Initials": "WJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Narita",
        "ForeName": "Masashi",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "M\u00fchlemann",
        "ForeName": "Kathrin",
        "Initials": "K"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Lancet Infect Dis",
    "NlmUniqueID": "101130150",
    "ISSNLinking": "1473-3099"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "8064-90-2",
      "NameOfSubstance": "Trimethoprim, Sulfamethoxazole Drug Combination"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "diagnosis",
        "drug therapy",
        "microbiology"
      ],
      "DescriptorName": "Communicable Diseases, Emerging"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Resistance, Multiple, Bacterial"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Environmental Exposure"
    },
    {
      "QualifierName": [
        "diagnosis",
        "drug therapy",
        "microbiology"
      ],
      "DescriptorName": "Gram-Positive Bacterial Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Microbial Sensitivity Tests"
    },
    {
      "QualifierName": [
        "diagnosis",
        "drug therapy",
        "microbiology"
      ],
      "DescriptorName": "Opportunistic Infections"
    },
    {
      "QualifierName": [
        "classification",
        "drug effects",
        "pathogenicity"
      ],
      "DescriptorName": "Stenotrophomonas maltophilia"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Trimethoprim, Sulfamethoxazole Drug Combination"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Water Microbiology"
    }
  ]
}